TERT promoter mutation subtypes and survival in stage I and II melanoma patients-Reference-Cited by-同舟云学术

TERT promoter mutation subtypes and survival in stage I and II melanoma patients

Published:2018-10-04 Issue:5 Volume:144 Page:1027-1036
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Andrés-Lencina Juan J.¹,Rachakonda Sivaramakrishna²,García-Casado Zaida³,Srinivas Nalini²,Skorokhod Alexander²,Requena Celia⁴,Soriano Virtudes⁵,Kumar Rajiv²⁶^ORCID,Nagore Eduardo⁴⁷^ORCID

Affiliation:

1. Department of Dermatology; Hospital Universitario 12 de Octubre; Madrid Spain

2. Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany

3. Laboratory of Molecular Biology; Instituto Valenciano de Oncología; València Spain

4. Department of Dermatology; Instituto Valenciano de Oncología; València Spain

5. Department of Medical Oncology; Instituto Valenciano de Oncología; València Spain

6. German Consortium for Translational Research, German Cancer Research Center; Heidelberg Germany

7. School of Medicine; Universidad Católica de Valencia “San Vicente Mártir”; València Spain

Funder

German Consortium for Translational Research (DKTK)

German Ministry of Education and Research (BMBF; TRANSCAN)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31780/fullpdf

Reference36 articles.

1. Cutaneous melanoma;Eggermont;Lancet,2014

2. From melanocytes to melanomas;Shain;Nature Rev Cancer,2016

3. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

4. Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance;Pritchard;Clin Cancer Res,2013

5. BRAF mutations are common somatic events in melanocytic nevi;Kumar;J Invest Dermatol,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility and Micro-Costing Framework for TERT Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical Practice;Diagnostics;2024-08-01

2. TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome;Human Pathology;2024-02

3. Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients;Pigment Cell & Melanoma Research;2023-12-28

4. Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations;Frontiers in Cell and Developmental Biology;2023-11-15

5. Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma;PLOS ONE;2023-11-10